His primary areas of investigation include Lymphoma, Pathology, Lymphomatoid papulosis, CD30 and Cancer research. His Lymphoma study deals with the bigger picture of Internal medicine. Marshall E. Kadin combines subjects such as Gene rearrangement, Clone and Antigen with his study of Pathology.
His study in Lymphomatoid papulosis is interdisciplinary in nature, drawing from both Anaplastic large-cell lymphoma, Lymphoproliferative disorders and Surgery. His studies deal with areas such as Relative risk and Cohort study as well as CD30. His Cancer research research incorporates elements of Cell culture and Receptor, Transforming growth factor beta, Signal transduction, Transforming growth factor.
His primary areas of study are Pathology, Lymphoma, CD30, Lymphomatoid papulosis and Cancer research. The various areas that Marshall E. Kadin examines in his Pathology study include T cell and Immunophenotyping. The study incorporates disciplines such as Surgery and Disease in addition to Lymphoma.
His CD30 research is multidisciplinary, incorporating perspectives in Reed–Sternberg cell, T-cell lymphoma and CD8. His Lymphomatoid papulosis study deals with Pathogenesis intersecting with Virus. His Cancer research study combines topics from a wide range of disciplines, such as Cell culture, Apoptosis, JUNB, Signal transduction and Anaplastic large-cell lymphoma.
Marshall E. Kadin mainly investigates Cancer research, Pathology, Lymphoma, Lymphomatoid papulosis and CD30. His studies in Cancer research integrate themes in fields like Anaplastic large-cell lymphoma, JUNB, Growth factor receptor inhibitor and Lymphocyte. His research integrates issues of Natural history and CD8 in his study of Pathology.
His Lymphoma study is associated with Internal medicine. His biological study spans a wide range of topics, including Dermatology, Lymphoproliferative disorders and Programmed cell death. The Oncology study combines topics in areas such as Immunology, Karyotype, Cohort and Chromosomal translocation.
Marshall E. Kadin mainly focuses on Lymphoma, Anaplastic large-cell lymphoma, Cancer research, Anaplastic lymphoma kinase and Large-cell lymphoma. All of his Lymphoma and Lymphomatoid papulosis and CD30 investigations are sub-components of the entire Lymphoma study. Marshall E. Kadin has researched Lymphomatoid papulosis in several fields, including Cell, Lymphoproliferative disorders, T cell, Stem cell and Transforming growth factor beta.
His CD30 study integrates concerns from other disciplines, such as CD30 Ligand, Transforming growth factor, Growth inhibition and Receptor complex. Anaplastic large-cell lymphoma is the subject of his research, which falls under Pathology. The concepts of his Pathology study are interwoven with issues in Immunophenotyping, Antigen and Lymphocyte.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Non‐hodgkin's lymphomas iv. clinicopathologic correlation in 405 cases
Stephen E. Jones;Zvi Fuks;Malcolm Bull;Marshall E. Kadin.
Randomized comparison of low-dose involved-field radiotherapy and no radiotherapy for children with Hodgkin's disease who achieve a complete response to chemotherapy.
James B. Nachman;Richard Sposto;Philip Herzog;Gerald S. Gilchrist.
Journal of Clinical Oncology (2002)
Ki-1 positive large cell lymphoma. A morphologic and immunologic study of 19 cases.
Bjarni A. Agnarsson;Marshall E. Kadin.
The American Journal of Surgical Pathology (1988)
Hodgkin's disease, lymphomatoid papulosis, and cutaneous T-cell lymphoma derived from a common T-cell clone
Thomas H. Davis;Cynthia C. Morton;Robert Miller-Cassman;Steven P. Balk.
The New England Journal of Medicine (1992)
Childhood Ki-1 lymphoma presenting with skin lesions and peripheral lymphadenopathy
ME Kadin;D Sako;N Berliner;W Franklin.
Leukemia of Large Granular Lymphocytes: Association with Clonal Chromosomal Abnormalities and Autoimmune Neutropenia, Thrombocytopenia, and Hemolytic Anemia
Thomas P. Loughran;Marshall E. Kadin;Gordon Starkebaum;Janis L. Abkowitz.
Annals of Internal Medicine (1985)
Aggressive peripheral T-cell lymphomas containing Epstein-Barr viral DNA: a clinicopathologic and molecular analysis.
Ih-Jen Su;Hong-Chung Hsieh;Kai-Hsin Lin;Wu-Ching Uen.
A small-cell-predominant variant of primary Ki-1 (CD30)+ T-cell lymphoma.
Marsha C. Kinney;Robert D. Collins;John P. Greer;James A. Whitlock.
The American Journal of Surgical Pathology (1993)
Erythrophagocytic Tγ Lymphoma
Marshall E. Kadin;Malek Kamoun;John Lamberg.
The New England Journal of Medicine (1981)
Activation of Jak/STAT proteins involved in signal transduction pathway mediated by receptor for interleukin 2 in malignant T lymphocytes derived from cutaneous anaplastic large T-cell lymphoma and Sezary syndrome.
Qian Zhang;Irena Nowak;Eric C. Vonderheid;Alain H. Rook.
Proceedings of the National Academy of Sciences of the United States of America (1996)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: